Xavier Cathelineau

Xavier Cathelineau

Auto-generated profile, based on publicly available information

Xavier Cathelineau

Paris, France

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Journal of Endourology
Verified
Journal Article
Closed access
FRFrançois Rozet
François Rozet
CACarlos Arroyo
Carlos Arroyo
XCXavier Cathelineau
Xavier Cathelineau
EBEric Barret
Eric Barret
DPDominique Prapotnich
Dominique Prapotnich
GVGuy Vallancien
Guy Vallancien
Purpose: To describe our preliminary experience with the extraperitoneal approach for laparoscopic radical prostatectomy. Patients and Methods: Between February and December 2002, we performed 100 laparoscopic radical prostatectomies by an extraperitoneal approach. Results: Of the procedures, 98 were completed as planned, while conversion to a transperitoneal approach was necessary in 2 patients with previous mesh hernia repair. The mean operative time was 163 minutes. The mean operative blood loss was 375 mL. The transfusion rate was 3%. No rectal, bowel, ureteral, or nervous injury was observed. There were no major complications. There were nine minor complications (four anastomotic leakages, one rectus muscle hematoma, four cases of acute urinary retention). The mean hospital stay was 6.1 days. Mean catheterization lasted 6 days. The pathologic stage was T2a, T2b, T2c, T3a, and T3b in 17%, 22%, 39%, 12%, and 10%, respectively. The mean Gleason score was 7. The margins were positive in 15% of the pT2 and in 35% of the pT3 tumors; 48% of the positive margins occurred in the first 25 cases. The median follow-up was 12 months; 93% of the patients had a serum prostate specific antigen concentration 20), the postoperative erection and intercourse rate was 64% and 43% in patients with bilateral and unilateral nervebundle preservation, respectively. Conclusion: The extraperitoneal technique is a reliable approach for laparoscopic radical prostatectomy. The choice between a transperitoneal or an extraperitoneal approach depends on the surgeon's experience.

8 October 2021 in Current Urology Reports
Verified
Journal Article
Closed access
PDF file
PMP. Macek
P. Macek
XCX. Cathelineau
X. Cathelineau
YBY. P. Barbe
Y. P. Barbe
RSRafael Sanchez-Salas
Rafael Sanchez-Salas
ARAlejandro Remigio Rodriguez
Alejandro Remigio Rodriguez

1 October 2017 in International braz j urol
Verified
Journal Article
Open access
PDF file
Cristina RedondoCristina Redondo
Cristina Redondo
VSVictor Srougi
Victor Srougi
JCJosé Batista da Costa
José Batista da Costa
MBMohammed Baghdad
Mohammed Baghdad
GVGuillermo Velilla
Guillermo Velilla
XCXavier Cathelineau
Xavier Cathelineau
Focal cryotherapy emerged as an efficient option to treat favorable and localized prostate cancer (PCa). The purpose of this video is to describe the procedure step by step. We present the case of a 68 year-old man with localized PCa in the anterior aspect of the prostate. The procedure is performed under general anesthesia, with the patient in lithotomy position. Briefly, the equipament utilized includes the cryotherapy console coupled with an ultrasound system, argon and helium gas bottles, cryoprobes, temperature probes and an urethral warming catheter. The procedure starts with a real-time trans-rectal prostate ultrasound, which is used to outline the prostate, the urethra and the rectal wall. The cryoprobes are pretested and placed in to the prostate through the perineum, following a grid template, along with the temperature sensors under ultrasound guidance. A cystoscopy confirms the right positioning of the needles and the urethral warming catheter is installed. Thereafter, the freeze sequence with argon gas is started, achieving extremely low temperatures (-40ºC) to induce tumor cell lysis. Sequentially, the thawing cycle is performed using helium gas. This process is repeated one time. Results among several series showed a biochemical disease-free survival between 71-93% at 9-70 month- follow-up, incontinence rates between 0-3.6% and erectile dysfunction between 0-42% (1-5). Focal cryotherapy is a feasible procedure to treat anterior PCa that may offer minimal morbidity, allowing good cancer control and better functional outcomes when compared to whole-gland treatment.

1 February 2021 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
WBWilly Baccaglini
Willy Baccaglini
FGFelipe A. Glina
Felipe A. Glina
CPCristiano Linck Pazeto
Cristiano Linck Pazeto
Luis G. MedinaLuis G. Medina
Luis G. Medina
FKFernando Korkes
Fernando Korkes
RSRafael Sanchez-Salas
Rafael Sanchez-Salas

1 June 2022 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
AGAnna Colomer Gallardo
Anna Colomer Gallardo
LCLuigi Candela
Luigi Candela
OROscar Buisan Rueda
Oscar Buisan Rueda
RSRoger Freixa Sala
Roger Freixa Sala
JCJavier Elias Cañavera
Javier Elias Cañavera
RSRafael Sanchez-Salas
Rafael Sanchez-Salas

1 June 2010 in Progrès en Urologie
Verified
Journal Article
Closed access
NBN. Berthon
N. Berthon
XPX. Plainard
X. Plainard
XCX. Cathelineau
X. Cathelineau
FRF. Rozet
F. Rozet
NCN. Cathala
N. Cathala
GVG. Vallancien
G. Vallancien